UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of ketamine and n-methyl- d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268

Neuroscience, 2003-01, Vol.117 (3), p.697-706

2003

Volltextzugriff (PDF)

Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression

Neuropharmacology, 2005-03, Vol.48 (4), p.492-502

2005

Volltextzugriff (PDF)

Schizophrenia and L-745, 870, a novel dopamine D4 receptor antagonist

Trends in pharmacological sciences (Regular ed.), 1997-06, Vol.18 (6), p.186-188

1997

Volltextzugriff (PDF)

The glycine/NMDA receptor antagonist, R‐(+)‐HA‐966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK‐801) in rodents

British journal of pharmacology, 1993-04, Vol.108 (4), p.1156-1163

1993

Volltextzugriff (PDF)

Genetic knockout and pharmacological blockade studies of the 5-HT 7 receptor suggest therapeutic potential in depression

Neuropharmacology, 2005, Vol.48 (4), p.492-502

2005

Volltextzugriff (PDF)

Contextual fear conditioning and baseline startle responses in the rat fear-potentiated startle test: a comparison of benzodiazepine/γ-aminobutyric acid-A receptor agonists

Behavioural pharmacology, 2000-09, Vol.11 (6), p.495-504

2000

Volltextzugriff (PDF)

Biphasic effects of intra‐accumbens histamine administration on spontaneous motor activity in the rat; a role for central histamine receptors

British journal of pharmacology, 1988-12, Vol.95 (4), p.1292-1302

1988

Volltextzugriff (PDF)

Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT1A receptor antagonist, WAY 100,635, in the rat

Neuropharmacology, 2000-06, Vol.39 (7), p.1222-1236

2000

Volltextzugriff (PDF)

Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT2C/2B receptor antagonists: neurochemical and behavioural studies

Neuropharmacology, 2000-11, Vol.39 (12), p.2318-2328

2000

Volltextzugriff (PDF)

Group II selective MGLU receptor agonists block ketamine-evoked glutamate release in the rat prefrontal cortex and hippocampus

Schizophrenia research, 2003-03, Vol.60 (1), p.111-112

2003

Volltextzugriff (PDF)

Evidence for accelerated desensitisation of 5-HT 2C receptors following combined treatment with fluoxetine and the 5-HT 1A receptor antagonist, WAY 100,635, in the rat

Neuropharmacology, 2000, Vol.39 (7), p.1222-1236

2000

Volltextzugriff (PDF)

Competitive and Glycine/NMDA Receptor Antagonists Attenuate Withdrawal-induced Behaviours and Increased Hippocampal Acetylcholine Efflux in Morphine-dependent Rats

Neuropharmacology, 1997-02, Vol.36 (2), p.241-250

1997

Volltextzugriff (PDF)

The behavioural and neurochemical profile of the putative dopamine D3 receptor agonist, (+)-PD 128907, in the rat

Neuropharmacology, 1996-03, Vol.35 (3), p.285-294

1996

Volltextzugriff (PDF)

R‐(+)‐HA‐966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine

British journal of pharmacology, 1991-08, Vol.103 (4), p.2037-2044

1991

Volltextzugriff (PDF)

Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT 2C/2B receptor antagonists: neurochemical and behavioural studies

Neuropharmacology, 2000, Vol.39 (12), p.2318-2328

2000

Volltextzugriff (PDF)

[Sar9, Met(O2)11]-substance P-induced chromodacryorrhea in gerbils; A model of NK1 receptor function

Neuropeptides (Edinburgh), 1993-04, Vol.24 (4), p.238-239

1993

Volltextzugriff (PDF)

Glycine/NMDA antagonists reduce amphetamine disruptions in prepulse inhibition in the rat

European neuropsychopharmacology, 1996-06, Vol.6, p.44-44

1996

Volltextzugriff (PDF)

Atypical neuroleptic profile in rodents of L-701,324, an antagonist at the glycine/NMDA receptor

European neuropsychopharmacology, 1996-06, Vol.6, p.139-139

1996

Volltextzugriff (PDF)

The behavioural and neurochemical profile of the putative dopamine D 3 receptor agonist, (+)-PD 128907, in the rat

Neuropharmacology, 1996-03, Vol.35 (3), p.285-294

1996

Volltextzugriff (PDF)

[Sar 9, Met(O 2) 11]-substance P-induced chromodacryorrhea in gerbils; A model of NK 1 receptor function

Neuropeptides (Edinburgh), 1993, Vol.24 (4), p.238-239

1993

Volltextzugriff (PDF)

The effects of GR127935, a putative 5-HT1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HTT concentration and behaviour in the guinea pig

Neuropharmacology, 1995-04, Vol.34 (4), p.383-392

1995

Volltextzugriff (PDF)

The anticonvulsant and behavioural profile of L‐687,414, a partial agonist acting at the glycine modulatory site on the N‐methyl‐D‐aspartate (NMDA) receptor complex

British journal of pharmacology, 1994-11, Vol.113 (3), p.729-736

1994

Volltextzugriff (PDF)

A functional role for hist amine in brain:-interactions with thyrotrophin releasing hormone ( TRH)

Bristow, L.J

1988

Volltextzugriff (PDF)

The effects of GR127935, a putative 5-HT 1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HTT concentration and behaviour in the guinea pig

Neuropharmacology, 1995, Vol.34 (4), p.383-392

1995

Volltextzugriff (PDF)

Effect of chronic intra‐accumbens administration of the TRH analogue CG3509 on histamine‐induced behaviour in the rat

British journal of pharmacology, 1989-07, Vol.97 (3), p.745-752

1989

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(35)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(13)
Rats
(13)
Animals
(12)
Pharmacology & Pharmacy
(12)
Biological And Medical Sciences
(11)
Male
(10)
Medical Sciences
(9)
Pharmacology. Drug Treatments
(9)
Neuropharmacology
(7)
Neurosciences
(7)
Neurosciences & Neurology
(7)
Behavior, Animal - Drug Effects
(6)
Rats, Sprague-Dawley
(6)
Neurotransmitters. Neurotransmission. Receptors
(5)
Behaviour
(4)
Desipramine
(4)
Electroconvulsive Shock
(4)
Locomotor Activity
(4)
Mice
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of ketamine and n-methyl- d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268

Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression

Schizophrenia and L-745, 870, a novel dopamine D4 receptor antagonist

The glycine/NMDA receptor antagonist, R‐(+)‐HA‐966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK‐801) in rodents

Genetic knockout and pharmacological blockade studies of the 5-HT 7 receptor suggest therapeutic potential in depression

Contextual fear conditioning and baseline startle responses in the rat fear-potentiated startle test: a comparison of benzodiazepine/γ-aminobutyric acid-A receptor agonists

Biphasic effects of intra‐accumbens histamine administration on spontaneous motor activity in the rat; a role for central histamine receptors

Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT1A receptor antagonist, WAY 100,635, in the rat

Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT2C/2B receptor antagonists: neurochemical and behavioural studies

Group II selective MGLU receptor agonists block ketamine-evoked glutamate release in the rat prefrontal cortex and hippocampus

Evidence for accelerated desensitisation of 5-HT 2C receptors following combined treatment with fluoxetine and the 5-HT 1A receptor antagonist, WAY 100,635, in the rat

Competitive and Glycine/NMDA Receptor Antagonists Attenuate Withdrawal-induced Behaviours and Increased Hippocampal Acetylcholine Efflux in Morphine-dependent Rats

The behavioural and neurochemical profile of the putative dopamine D3 receptor agonist, (+)-PD 128907, in the rat

R‐(+)‐HA‐966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine

Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT 2C/2B receptor antagonists: neurochemical and behavioural studies

[Sar9, Met(O2)11]-substance P-induced chromodacryorrhea in gerbils; A model of NK1 receptor function

Glycine/NMDA antagonists reduce amphetamine disruptions in prepulse inhibition in the rat

Atypical neuroleptic profile in rodents of L-701,324, an antagonist at the glycine/NMDA receptor

The behavioural and neurochemical profile of the putative dopamine D 3 receptor agonist, (+)-PD 128907, in the rat

[Sar 9, Met(O 2) 11]-substance P-induced chromodacryorrhea in gerbils; A model of NK 1 receptor function

The effects of GR127935, a putative 5-HT1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HTT concentration and behaviour in the guinea pig

The anticonvulsant and behavioural profile of L‐687,414, a partial agonist acting at the glycine modulatory site on the N‐methyl‐D‐aspartate (NMDA) receptor complex

A functional role for hist amine in brain:-interactions with thyrotrophin releasing hormone ( TRH)

The effects of GR127935, a putative 5-HT 1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HTT concentration and behaviour in the guinea pig

Effect of chronic intra‐accumbens administration of the TRH analogue CG3509 on histamine‐induced behaviour in the rat

Suchergebnisse filtern